EXEL — EXELIXIS INC
Public company
InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.
Sourced from SEC EDGAR public filings
Why are billionaires buying EXEL?
Built from public SEC filings and public economic data. Not a recommendation.
Why? — Evidence & Confidence ▾
Of 2 tracked investors who changed their EXEL position last quarter, 1 bought and 1 sold (50% buy-side). Macro conditions are mixed for this sector (Macro Tailwind 56/100 in a Overheat regime).
- +1 tracked investor added or increased positions last quarter (Paul Tudor Jones)
- +4 tracked investors reported holding EXEL at their latest filing
- +Macro Health is 56/100 in a Overheat regime — historically acceptable for this sectorsource
- −1 tracked investor reduced or exited last quarter (1 reduced, 0 sold out)
- −13F data is disclosed up to 45 days after quarter end — positions may have changed since
- · 13F disclosure lag (up to 45 days)
- · Tracked investors are a sample, not the whole market
- · Sector regime fit is a historical average, not a guarantee
Every InvestorLens score shows its evidence — including what argues against it. Model conviction-v1 · generated 9/18/2026.
About EXELIXIS INC (EXEL)
EXELIXIS INC (EXEL) appears in the most recent 13F filings of 4 tracked institutional investors. The largest disclosed position is held by Izzy Englander (Millennium Management), valued at $78M. Across recent filings, tracked investors recorded 5 new positions, 5 increased, 7 reduced, and 2 exited. All data sourced from SEC 13F filings.
Based on recent institutional activity in EXEL
How many top investors track EXEL
A small number of top investors own this.
EXEL Ownership Composition
How EXELIXIS INC is held across tracked investor types, based on reported 13F positions.
- Multi-Strategy / Quant80.1%
- Macro19.9%
Tracked investors currently reporting EXEL
1 tracked investor has since exited this position — listed separately below.
- Izzy EnglanderJun 30, 2026Millennium ManagementShares1.4MValue$78.3M% Portfolio0.03%
- Ken GriffinJun 30, 2026Citadel AdvisorsShares223.7KValue$12.2M% Portfolio0.00%
- Ray DalioJun 30, 2026Bridgewater AssociatesShares400.9KValue$21.8M% Portfolio0.09%
- Paul Tudor JonesJun 30, 2026Tudor Investment CorpShares12.3KValue$671K% Portfolio0.00%
Previously held EXEL
These investors reported EXEL in an earlier quarter but not in their most recent 13F. Figures below are their last reported position, not a current holding.
| Investor | Firm | Last reported shares | Value then | Last held |
|---|---|---|---|---|
| Steve Cohen | Point72 Asset Management | 856K | $37.5M | Dec 31, 2025 |
Recent activity
- New$28.5MFeb 17, 2026
- New$307KMay 14, 2025
- Increased$919.6K(150.93%)Aug 13, 2025
- Increased$34.8M(3940.09%)Nov 13, 2025
- Increased$40.6M(9.82%)Feb 13, 2026
- Reduced$20.6M(-48.04%)May 15, 2026
- Reduced$21.8M(-16.66%)Aug 14, 2026
- New$5.2MNov 14, 2024
- Sold$0(-100.00%)Feb 14, 2025
- New$37.5MFeb 17, 2026
- Sold$0(-100.00%)May 15, 2026
- $3.3MAug 14, 2024
- Reduced$3.3M(-12.89%)Nov 14, 2024
- Reduced$2.7M(-35.25%)Feb 14, 2025
- Reduced$2.6M(-13.45%)May 15, 2025
- Increased$4.9M(56.19%)Aug 14, 2025
- Reduced$3.7M(-19.06%)Dec 9, 2025
- Reduced$300.2K(-90.31%)May 15, 2026
- Increased$671K(76.17%)Aug 14, 2026
Frequently asked questions
- How many institutional investors hold EXEL?
- 4 tracked institutional investors disclosed a position in EXEL (EXELIXIS INC) in their most recent 13F filing.
- Who is the largest institutional holder of EXEL?
- Izzy Englander, Millennium Management, holds the largest disclosed position in EXEL, valued at $78M.
- Did institutional ownership of EXEL increase or decrease?
- Across recent 13F filings, tracked investors recorded 5 new positions, 5 increased, 7 reduced, and 2 fully exited EXEL.
- Where does this EXEL ownership data come from?
- SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.